Literature DB >> 8550987

Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.

C Giannini1, V Thiers, J B Nousbaum, L Stuyver, G Maertens, C Bréchot.   

Abstract

BACKGROUND/AIMS: The importance of determining the hepatitis C virus genotype has increased since several authors have described a good correlation between hepatitis C virus genotype and response to interferon treatment or to disease severity. It is thus of particular importance to develop reliable assays for hepatitis C virus genotyping.
METHODS: We have comparatively analyzed hepatitis C virus genotypes of 208 French and Italian chronically infected patients using genotype-specific primers polymerase chain reaction in the capsid region and a genotype-specific probe-based assay in the 5' untranslated region (LiPA).
RESULTS: We found a good concordance between the two assays for the prevalent genotypes in our regions (145/174). The nucleotide sequences in the 5'UTR and capsid domain were investigated to determine the molecular basis of some discordant results. This analysis showed that the genotype-specific probe-based assay gave more consistent results, probably because this technique is based on several probes distributed along the 5'UTR to reveal each genotype. In contrast, the low variability of 5'UTR did not always permit classification of the hepatitis C virus genotype 1 subtypes. We also found some problems, using genotype-specific primers polymerase chain reaction, for less represented genotypes; in particular, in the presence of type 2a/III we obtained more discordant results. This observation is of importance in view of the potential association of this genotype with mild liver disease and a good response to interferon-a treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550987

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

2.  Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay.

Authors:  S Navas; I Castillo; J Martín; J A Quiroga; J Bartolomé; V Carreño
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 3.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.

Authors:  O Ohno; M Mizokami; R R Wu; M G Saleh; K Ohba; E Orito; M Mukaide; R Williams; J Y Lau
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients.

Authors:  X Forns; M D Maluenda; F X López-Labrador; S Ampurdanès; E Olmedo; J Costa; P Simmonds; J M Sánchez-Tapias; M T Jimenez De Anta; J Rodés
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Randomised Trial of Two Different Daily Doses of Interferon-α versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C.

Authors:  G Montalto; S Tripi; O Vuturo; G Di Gaetano; M Soresi; A Spadaro; A Aiello; M Russello; R Benigno; R Siciliano
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

7.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

8.  Detection and typing of hepatitis C RNA in liver biopsies and its relation to histopathology.

Authors:  G Cathomas; C E McGandy; L M Terracciano; F Gudat; L Bianchi
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

9.  No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.

Authors:  P Cacoub; L Musset; P Hausfater; P Ghillani; F L Fabiani; F Charlotte; E Angevin; P Opolon; T Poynard; J C Piette; B Autran
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Acetylcysteine therapy for chronic hepatitis C: are its effects synergistic with interferon alpha? A pilot study.

Authors:  S Tripi; G D Gaetano; M Soresi; A Carroccio; G Bonfissuto; A Savi; O Vuturo; G Montalto
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.